You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

TOLECTIN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Tolectin patents expire, and when can generic versions of Tolectin launch?

Tolectin is a drug marketed by Ortho Mcneil Janssen and is included in two NDAs.

The generic ingredient in TOLECTIN is tolmetin sodium. There are twelve drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the tolmetin sodium profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Tolectin

A generic version of TOLECTIN was approved as tolmetin sodium by RISING on May 27th, 1993.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for TOLECTIN?
  • What are the global sales for TOLECTIN?
  • What is Average Wholesale Price for TOLECTIN?
Summary for TOLECTIN
US Patents:0
Applicants:1
NDAs:2
Raw Ingredient (Bulk) Api Vendors: 97
Patent Applications: 5,124
DailyMed Link:TOLECTIN at DailyMed
Drug patent expirations by year for TOLECTIN

US Patents and Regulatory Information for TOLECTIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ortho Mcneil Janssen TOLECTIN tolmetin sodium TABLET;ORAL 017628-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Ortho Mcneil Janssen TOLECTIN 600 tolmetin sodium TABLET;ORAL 017628-002 Mar 8, 1989 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Ortho Mcneil Janssen TOLECTIN DS tolmetin sodium CAPSULE;ORAL 018084-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.